Latest News Aug 30, 2022 Esperion to Participate in Upcoming September Investor Conferences Aug 26, 2022 Esperion Announces Bempedoic Acid (NEXLETOL®) Recommended as Oral Non-Statin Therapy for LDL-Cholesterol Lowering in American College of Cardiology Expert Consensus Decision Pathway View All News Dark Blue View All News Show all Latest Quarterly Results Esperion Reports Second Quarter 2022 Financial Results and Provides Company Update Form 10-Q View All Earnings View All Earnings Corporate Presentation Download PDF Events Upcoming Events More events are coming soon. Past Events Sep 20, 2022 at 8:00 AM EDT Special Meeting of Stockholders Sep 13, 2022 at 11:30 AM EDT H.C. Wainwright Annual Global Investment Conference View All Events View All Events
Aug 26, 2022 Esperion Announces Bempedoic Acid (NEXLETOL®) Recommended as Oral Non-Statin Therapy for LDL-Cholesterol Lowering in American College of Cardiology Expert Consensus Decision Pathway